Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

✍ Scribed by C.J.A. Punt; S. Suciu; M.A. Gore; J. Koller; W.H.J. Kruit; J. Thomas; P. Patel; D. Lienard; A.M.M. Eggermont; U. Keilholz

• Book ID: 116429142
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 150 KB
• Volume: 42
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2006.08.012